ERBB3 mediates the PI3K/AKT/mTOR pathway to alter the epithelial‑mesenchymal transition in cervical cancer and predict immunity filtration outcome
- Authors:
- Xiaoyue Yang
- Weipei Zhu
-
Affiliations: Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215000, P.R. China - Published online on: February 15, 2023 https://doi.org/10.3892/etm.2023.11845
- Article Number: 146
-
Copyright : © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Cohen PA, Jhingran A, Oaknin A and Denny L: Cervical cancer. Lancet. 393:169–182. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Yugawa T and Kiyono T: Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: Novel functions of E6 and E7 oncoproteins. Rev Med Virol. 19:97–113. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Zhang L, Wu J, Ling MT, Zhao L and Zhao KN: The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses. Mol Cancer. 14(87)2015.PubMed/NCBI View Article : Google Scholar | |
|
Bossler F, Hoppe-Seyler K and Hoppe-Seyler F: PI3K/AKT/mTOR signaling regulates the virus/host cell crosstalk in HPV-positive cervical cancer cells. Int J Mol Sci. 20(2188)2019.PubMed/NCBI View Article : Google Scholar | |
|
Shi X, Wang J, Lei Y, Cong C, Tan D and Zhou X: Research progress on the PI3K/AKT signaling pathway in gynecological cancer. Mol Med Rep. 19:4529–4535. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Senga SS and Grose RP: Hallmarks of cancer-the new testament. Open Biol. 11(200358)2021.PubMed/NCBI View Article : Google Scholar | |
|
O'Donnell JS, Teng MWL and Smyth MJ: Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol. 16:151–167. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Fukumura D, Kloepper J, Amoozgar Z, Duda DG and Jain RK: Enhancing cancer immunotherapy using antiangiogenics: Opportunities and challenges. Nat Rev Clin Oncol. 15:325–340. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Aiello NM and Kang Y: Context-dependent EMT programs in cancer metastasis. J Exp Med. 216:1016–1026. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Taki M, Abiko K, Ukita M, Murakami R, Yamanoi K, Yamaguchi K, Hamanishi J, Baba T, Matsumura N and Mandai M: Tumor immune microenvironment during epithelial-mesenchymal transitionthe review of the loop between EMT and immunosuppression. Clin Cancer Res. 27:4669–4679. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Dongre A, Rashidian M, Reinhardt F, Bagnato A, Keckesova Z, Ploegh HL and Weinberg RA: Epithelial-to-mesenchymal transition contributes to immunosuppression in breast carcinomas. Cancer Res. 77:3982–3989. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Hoxhaj G and Manning BD: The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 20:74–88. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Coussy F, El Botty R, Lavigne M, Gu C, Fuhrmann L, Briaux A, de Koning L, Dahmani A, Montaudon E, Morisset L, et al: Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers. J Hematol Oncol. 13(13)2020.PubMed/NCBI View Article : Google Scholar | |
|
Li M, Liu F, Zhang F, Zhou W, Jiang X, Yang Y, Qu K, Wang Y, Ma Q, Wang T, et al: Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis. Gut. 68:1024–1033. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Ross JS, Fakih M, Ali SM, Elvin JA, Schrock AB, Suh J, Vergilio JA, Ramkissoon S, Severson E, Daniel S, et al: Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3. Cancer. 124:1358–1373. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Van Lengerich B, Agnew C, Puchner EM, Huang B and Jura N: EGF and NRG induce phosphorylation of HER3/ERBB3 by EGFR using distinct oligomeric mechanisms. Proc Natl Acad Sci USA. 114:E2836–E2845. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Sithanandam G and Anderson LM: The ERBB3 receptor in cancer and cancer gene therapy. Cancer Gene Ther. 15:413–448. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Moghbeli M, Makhdoumi Y, Delgosha MS, Aarabi A, Dadkhah E, Memar B, Abdollahi A and Abbaszadegan MR: ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer. Biol Res. 52(2)2008.PubMed/NCBI View Article : Google Scholar | |
|
Shi DM, Li LX, Bian XY, Shi XJ, Lu LL, Zhou HX, Pan TJ, Zhou J, Fan J and Wu WZ: miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling. J Exp Clin Cancer Res. 37(294)2018.PubMed/NCBI View Article : Google Scholar | |
|
Vivian J, Rao AA, Nothaft FA, Ketchum C, Armstrong J, Novak A, Pfeil J, Narkizian J, Deran AD, Musselman-Brown A, et al: Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 35:314–316. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G, et al: EMT International Association (TEMTIA). Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 21:341–352. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Den Boon JA, Pyeon D, Wang SS, Horswill M, Schiffman M, Sherman M, Zuna RE, Wang Z, Hewitt SM, Pearson R, et al: Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling. Proc Natl Acad Sci USA. 112:E3255–E3264. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M and Murty VV: Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression. Genes Chromosomes Cancer. 47:755–765. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Edgar R, Domrachev M and Lash AE: Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30:207–210. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al: NCBI GEO: Archive for functional genomics data sets-update. Nucleic Acids Res. 41:D991–D995. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Smyth GK: Limma: Linear models for microarray data. Bioinformatics and computational biology solutions using R and Bioconductor. Springer, New York, NY, 2005. 397-420. | |
|
Gu Z, Eils R and Schlesner M: Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 32:2847–2849. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, et al: Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 39:782–795. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Walter W, Sánchez-Cabo F and Ricote M: GOplot: An R package for visually combining expression data with functional analysis. Bioinformatics. 31:2912–2914. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T and Yamanishi Y: KEGG for linking genomes to life and the environment. Nucleic Acids Res. 36(Database issue):D480–D484. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Yu G, Wang LG, Han Y and He QY: clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS. 16:284–287. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Lanczky A and Gyorffy B: Web-based survival analysis tool tailored for medical research (KMplot): Development and implementation. J Med Internet Res. 23(e27633)2021.PubMed/NCBI View Article : Google Scholar | |
|
Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV, et al: An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 173:400–416.e11. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Goel AL and Wu SM: Determination of ARL and a contour nomogram for CUSUM charts to control normal mean. Technometrics. 13:221–230. 1971. | |
|
Han H, Cho JW, Lee S, Yun A, Kim H, Bae D, Yang S, Kim CY, Lee M, Kim E, et al: TRRUST v2: An expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 46:D380–D386. 2018.PubMed/NCBI View Article : Google Scholar | |
|
R Core Team: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, 2013. http://www.R-project.org/. | |
|
Jeppson H and Hofmann H: Generalized Mosaic Plots in the ggplot2 Framework: Exploratory analysis of high-dimensional data with visual tools 17, 2021. https://rdrr.io/cran/ggmosaic/. | |
|
Csardi G and Nepusz T: The igraph software package for complex network research. InterJournal Complex Systems. 1695:1–9. 2006. | |
|
Gustavsson EK, Zhang D, Reynolds RH, et al: ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2. Bioinformatics. 38(15):3844–3846. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Kassambara A, Kosinski M and Biecek P: Package ‘survminer’. Drawing Survival Curves using ‘ggplot2’(R package version 03 1), 2017. | |
|
Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 543:378–384. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Yang X, Chen Y, Li M and Zhu W: ERBB3 methylation and immune infiltration in tumor microenvironment of cervical cancer. Sci Rep. 12(8112)2022.PubMed/NCBI View Article : Google Scholar | |
|
Soto D, Song C and McLaughlin-Drubin ME: Epigenetic alterations in human papillomavirus-associated cancers. Viruses. 9(248)2017.PubMed/NCBI View Article : Google Scholar | |
|
Senapati R, Senapati NN and Dwibedi B: Molecular mechanisms of HPV mediated neoplastic progression. Infect Agent Cancer. 11(59)2016.PubMed/NCBI View Article : Google Scholar | |
|
Narisawa-Saito M and Kiyono T: Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins. Cancer Sci. 98:1505–1511. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Martinez-Zapien D, Ruiz FX, Poirson J, Mitschler A, Ramirez J, Forster A, Cousido-Siah A, Masson M, Pol SV, Podjarny A, et al: Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53. Nature. 529:541–545. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Karamanou K, Franchi M, Vynios D and Brézillon S: Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator. Semin Cancer Biol. 62:125–133. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Yang HL, Thiyagarajan V, Shen PC, Mathew DC, Lin KY, Liao JW and Hseu YC: Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis. J Exp Clin Cancer Res. 38(186)2019.PubMed/NCBI View Article : Google Scholar | |
|
Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, Zhang B, Meng Q, Yu X and Shi S: Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: New findings and future perspectives. Mol Cancer. 20(131)2021.PubMed/NCBI View Article : Google Scholar | |
|
Looi CK, Chung FFL, Leong CO, Wong SF, Rosli R and Mai SW: Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment. J Exp Clin Cancer Res. 38(162)2019.PubMed/NCBI View Article : Google Scholar | |
|
Cheng YQ, Wang SB, Liu JH, Jin L, Liu Y, Li CY, Su YR, Liu YR, Sang X, Wan Q, et al: Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours. Cell Prolif. 53(e12865)2020.PubMed/NCBI View Article : Google Scholar | |
|
Li D and Wu M: Pattern recognition receptors in health and diseases. Signal Transduct Target Ther. 6(291)2021.PubMed/NCBI View Article : Google Scholar | |
|
Mendes F, Domingues C, Rodrigues-Santos P, Abrantes AM, Gonçalves AC, Estrela J, Encarnação J, Pires AS, Laranjo M, Alves V, et al: The role of immune system exhaustion on cancer cell escape and anti-tumor immune induction after irradiation. Biochim Biophys Acta. 1865:168–175. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Liu Y and Cao X: Immunosuppressive cells in tumor immune escape and metastasis. J Mol Med (Berl). 94:509–522. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Che Y, Yang Y, Suo J, An Y and Wang X: Induction of systemic immune responses and reversion of immunosuppression in the tumor microenvironment by a therapeutic vaccine for cervical cancer. Cancer Immunol Immunother. 69:2651–2664. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Jayshree RS: The immune microenvironment in human papilloma virus-induced cervical lesions-evidence for estrogen as an immunomodulator. Front Cell Infect Microbiol. 11(649815)2021.PubMed/NCBI View Article : Google Scholar | |
|
Welters MJ, van der Sluis TC, van Meir H, Loof NM, van Ham VJ, van Duikeren S, Santegoets SJ, Arens R, de Kam ML, Cohen AF, et al: Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses. Sci Transl Med. 8(334ra52)2016.PubMed/NCBI View Article : Google Scholar | |
|
Todd RW, Roberts S, Mann CH, Luesley DM, Gallimore PH and Steele JC: Human papillomavirus (HPV) type 16-specific CD8+ T cell responses in women with high grade vulvar intraepithelial neoplasia. Int J Cancer. 108:857–862. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Torres-Poveda K, Bahena-Román M, Madrid-González C, Burguete-García AI, Bermúdez-Morales VH, Peralta-Zaragoza O and Madrid-Marina V: Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia. World J Clin Oncol. 5:753–763. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Kalathil SG and Thanavala Y: High immunosuppressive burden in cancer patients: A major hurdle for cancer immunotherapy. Cancer Immunol Immunother. 65:813–819. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Huang YK, Wang M, Sun Y, Di Costanzo N, Mitchell C, Achuthan A, Hamilton JA, Busuttil RA and Boussioutas A: Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry. Nat Commun. 10(3928)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Y and Zhang Z: The history and advances in cancer immunotherapy: Understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 17:807–821. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Chao MP, Weissman IL and Majeti R: The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol. 24:225–232. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Feng M, Jiang W, Kim BYS, Zhang CC, Fu YX and Weissman IL: Phagocytosis checkpoints as new targets for cancer immunotherapy. Nat Rev Cancer. 19:568–586. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Oronsky B, Carter C, Reid T, Brinkhaus F and Knox SJ: Just eat it: A review of CD47 and SIRP-α antagonism. Semin Oncol. 47:117–124. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Li Z, Li Y, Gao J, Fu Y, Hua P, Jing Y, Cai M, Wang H and Tong T: The role of CD47-SIRPα immune checkpoint in tumor immune evasion and innate immunotherapy. Life Sci. 273(119150)2021.PubMed/NCBI View Article : Google Scholar | |
|
Huang CY, Ye ZH, Huang MY and Lu JJ: Regulation of CD47 expression in cancer cells. Transl Oncol. 13(100862)2020.PubMed/NCBI View Article : Google Scholar | |
|
Yang H, Shao R, Huang H, Wang X, Rong Z and Lin Y: Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPα axis. Cancer Med. 8:4245–4253. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Braicu EI, Gasimli K, Richter R, Nassir M, Kümmel S, Blohmer JU, Yalcinkaya I, Chekerov R, Ignat I, Ionescu A, et al: Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer-results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial. Anticancer Res. 34:385–391. 2014.PubMed/NCBI | |
|
Riani M, Le Jan S, Plée J, Durlach A, Le Naour R, Haegeman G, Bernard P and Antonicelli F: Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes. J Allergy Clin Immunol. 139:863–872.e3. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Yi W, Tu MJ, Liu Z, Zhang C, Batra N, Yu AX and Yu AM: Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics. Acta Pharm Sin B. 10:159–170. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Vasconcelos RC, de Oliveira Moura JM, Junior VLB, da Silveira ÉJ and de Souza LB: Immunohistochemical expression of GLUT-1, GLUT-3, and carbonic anhydrase IX in benign odontogenic lesions. J Oral Pathol Med. 45:712–717. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, Giamarellos-Bourboulis EJ, Martens JH, Rao NA, Aghajanirefah A, et al: mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science. 345(1250684)2014.PubMed/NCBI View Article : Google Scholar | |
|
Giovanelli P, Sandoval TA and Cubillos-Ruiz JR: Dendritic cell metabolism and function in tumors. Trends Immunol. 40:699–718. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Kim IS and Zhang XHF: One microenvironment does not fit all: Heterogeneity beyond cancer cells. Cancer Metastasis Rev. 35:601–629. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Sobral-Leite M, Salomon I, Opdam M, Kruger DT, Beelen KJ, van der Noort V, van Vlierberghe RLP, Blok EJ, Giardiello D, Sanders J, et al: Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes. Breast Cancer Res. 21(90)2019.PubMed/NCBI View Article : Google Scholar | |
|
Rivera LB, Meyronet D, Hervieu V, Frederick MJ, Bergsland E and Bergers G: Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy. Cell Rep. 11:577–591. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Lambertz U, Silverman JM, Nandan D, McMaster WR, Clos J, Foster LJ and Reiner NE: Secreted virulence factors and immune evasion in visceral leishmaniasis. J Leukoc Biol. 91:887–899. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Crane CA, Panner A, Murray JC, Wilson SP, Xu H, Chen L, Simko JP, Waldman FM, Pieper RO and Parsa AT: PI (3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer. Oncogene. 28:306–312. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Bahrami A, Hasanzadeh M, Hassanian SM, ShahidSales S, Ghayour-Mobarhan M, Ferns GA and Avan A: The potential value of the PI3K/Akt/mTOR signaling pathway for assessing prognosis in cervical cancer and as a target for therapy. J Cell Biochem. 118:4163–4169. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Chai J, Modak C, Mouazzen W, Narvaez R and Pham J: Epithelial or mesenchymal: Where to draw the line? Biosci Trends. 4:130–142. 2010.PubMed/NCBI | |
|
Gerber TS, Ridder DA, Schindeldecker M, Weinmann A, Duret D, Breuhahn K, Galle PR, Schirmacher P, Roth W, Lang H and Straub BK: Constitutive occurrence of E: N-cadherin heterodimers in adherens junctions of hepatocytes and derived tumors. Cells. 11(2507)2022.PubMed/NCBI View Article : Google Scholar | |
|
Deshmukh AP, Vasaikar SV, Tomczak K, Tripathi S, den Hollander P, Arslan E, Chakraborty P, Soundararajan R, Jolly MK, Rai K, et al: Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing. Proc Natl Acad Sci USA. 118(e2102050118)2021.PubMed/NCBI View Article : Google Scholar | |
|
Suarez-Carmona M, Lesage J, Cataldo D and Gilles C: EMT and inflammation: Inseparable actors of cancer progression. Mol Oncol. 11:805–823. 2017.PubMed/NCBI View Article : Google Scholar |
